Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital

PURPOSE: This study was performed to determine the clinical biomarkers and cytokines that may be associated with disease progression and in-hospital mortality in a cohort of hospitalized patients with RT-PCR confirmed moderate to severe COVID-19 infection from October 2020 to September 2021, during...

Descripción completa

Detalles Bibliográficos
Autores principales: Punzalan, Felix Eduardo R., Aherrera, Jaime Alfonso M., de Paz-Silava, Sheriah Laine M., Mondragon, Alric V., Malundo, Anna Flor G., Tan, Joanne Jennifer E., Tantengco, Ourlad Alzeus G., Quebral, Elgin Paul B., Uy, Mary Nadine Alessandra R., Lintao, Ryan C. V., Dela Rosa, Jared Gabriel L., Mercado, Maria Elizabeth P., Avenilla, Krisha Camille, Poblete, Jonnel B., Albay, Albert B., David-Wang, Aileen S., Alejandria, Marissa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011458/
https://www.ncbi.nlm.nih.gov/pubmed/36926338
http://dx.doi.org/10.3389/fimmu.2023.1123497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011458/
https://www.ncbi.nlm.nih.gov/pubmed/36926338
http://dx.doi.org/10.3389/fimmu.2023.1123497

Ejemplares similares